YiChang HEC ChangJiang Ph... (YIHCF)

PNK: YIHCF · Real-Time Price · USD

0.55

0.00 (0.00%)

At close: Apr 30, 2025, 8:00 PM

YiChang HEC ChangJiang Pharmaceutical Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	6.29B	3.74B	913.79M	2.35B	6.22B	2.51B	1.6B	941.5M
Cost of Revenue	1.31B	898.88M	430.09M	351.55M	921.82M	398.81M	280.42M	214.23M
Gross Profit	4.99B	2.85B	483.7M	2B	5.3B	2.11B	1.32B	727.27M
Operating Income	2.35B	322.72M	-458.11M	833.69M	2.53B	1.08B	762.48M	419.57M
Interest Income	57.77M	274.91M	232.46M	219.22M	168.47M	13.18M	10.45M	871K
Pretax Income	2.13B	39.42M	-667.18M	1.01B	2.27B	1.1B	748.2M	453.07M
Net Income	1.99B	76.6M	-587.65M	839.46M	1.92B	942.54M	647.1M	380.6M
Selling & General & Admin	1.94B	1.55B	883.25M	1.47B	2.87B	1.04B	565.08M	313.6M
Research & Development	192.29M	129.61M	136.65M	119.43M	162.62M	224.1M	96.92M	64.24M
Other Expenses	499.8M	172K	60K	255.2M	-4.61M	5.51M	-337K	-2M
Operating Expenses	2.63B	2.53B	918.42M	766.91M	2.86B	1.02B	583.4M	275.07M
Interest Expense	227.4M	281.65M	243.81M	244.21M	204.5M	1.42M	4.29M	7.23M
Selling & Marketing Expenses	1.55B	1.22B	521.67M	1.15B	2.36B	653.65M	372.09M	180.89M
Cost & Expenses	3.94B	3.43B	1.35B	1.12B	3.79B	1.42B	863.82M	489.31M
Income Tax Expense	270.94M	9.82M	79.46M	173.02M	361.87M	201.11M	121.84M	72.47M
Shares Outstanding (Basic)	881.69M	879.97M	877.09M	1.11B	1.01B	904.05M	903.81M	901.63M
Shares Outstanding (Diluted)	879.97M	879.97M	879.97M	1.11B	1.01B	904.05M	903.81M	901.63M
EPS (Basic)	2.26	0.09	-0.67	0.95	2.16	1.04	0.72	0.42
EPS (Diluted)	2.26	0.09	-0.67	0.53	2.07	1.04	0.72	0.42
EBITDA	2.75B	691.48M	-206.55M	950.24M	2.61B	1.14B	806.27M	447.01M
EBIT	2.35B	322.72M	-423.38M	833.69M	2.53B	1.1B	752.48M	460.3M
Depreciation & Amortization	391.27M	377.36M	259.82M	122.73M	86.19M	61.09M	43.8M	27.45M